Height in children who are treated with dialysis and undergo kidney transplantion
- Authors: Baiko S.1, Sukalo A.1,2
-
Affiliations:
- Belorussian State Medical University
- National Academy of Sciences of Belarus
- Issue: Vol 29, No 2 (2018)
- Pages: 49-53
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/117208
- DOI: https://doi.org/10.29296/25877305-2018-02-12
- ID: 117208
Cite item
Open Access
Access granted
Abstract
The paper shows height trends in 118 children who are treated with dialysis and have undergone kidney transplantation. At the start of renal replacement treatment, the height standard deviation scores (SDS) in the patients were -1.16±1.74 with a need for growth hormone therapy in 28%.
Keywords
Full Text
About the authors
S. Baiko
Belorussian State Medical University
Email: baiko@yandex.ru
A. Sukalo
Belorussian State Medical University; National Academy of Sciences of Belarus
References
- Fine R. Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective // Pediatr. Nephrol. - 2010; 25 (4): 725-32.
- Kuizon B., Salusky I. Growth retardation in children with chronic renal failure // J. Bone Miner. Res. - 1999; 14 (10): 1680-90.
- Tonshoff B., Schaefer F., Mehls O. Disturbance of growth hormone - insulinlike growth factor axis in uraemia. Implications for recombinant human growth hormone treatment // Pediatr. Nephrol. - 1990; 4 (6): 654-62.
- Furth S., Hwang W., Yang C. et al. Growth failure, risk of hospitalization and death for children with end-stage renal disease // Pediatr. Nephrol. - 2002; 17 (6): 450-5.
- Rosenkranz J., Reichwald-Klugger E., Oh J. et al. Psychosocial rehabilitation and satisfaction with life in adults with childhood-onset of end-stage renal disease // Pediatr. Nephrol. - 2005; 20 (9): 1288-94.
- van Huis M., Bonthuis M., Sahpazova E. et al. Considerable variations in growth hormone policy and prescription in paediatric end-stage renal disease across European countries - a report from the ESPN / ERA-EDTA registry // Nephrol. Dial. Transplant. - 2016; 31 (4): 609-19.
- Rees L. Growth hormone therapy in children with CKD after more than two decades of practice // Pediatr. Nephrol. - 2016; 31 (9): 1421-35.
- PrimaryRenalDisease (PRD) codes - ERA-EDTARegistry / ERA-EDTA [Электронный ресурс]. - 2012. Режим доступа: https://www.era-edta-reg.org/ files/annualreports/pdf/PRD_code_list.pdf - Дата доступа: 12.12.2017.
- Schwartz G., Munoz A., Schneider M. et al. New equations to estimate GFR in children with CKD // J. Am. Soc. Nephrol. - 2009; 20 (3): 629-37.
- Ляликов С.А., Сукало А.В., Кузнецов О.Е. Центильные характеристики антропометрических и лабораторных показателей у детей в современный период: инструкция по применению / Гродно, 2009; 94 с.
- ESRD Among Children, Adolescents, and Young Adults / 2017 USRDS Annual data report [Электронный ресурс]. - 2017. Режим доступа: https://www. usrds.org/2017/view/v2_07.aspx - Дата доступа: 06.01.2018.
- Молчанова М.С., Петросян Э.К., Казымова С.Э. и др. Анализ нарушения роста и веса у детей с хронической болезнью почек II-V стадий в России по данным Российского регистра детей с ХПН // Клин. нефрология. - 2011; 22 (8): 26-30.
Supplementary files
